Myths About NIR Photon Skincare Devices That Cost Buyers Money
More emitters does not mean more output, NIR is not a laser, and no consumer light device reaches muscle. Five assumptions that distort sourcing decisions.
The first myth is that a higher LED count means a stronger device. What matters is the irradiance arriving at the skin, which depends on emitter efficiency, the optic in front of it and the distance. A 60-emitter array of low-output parts and a 24-emitter array of well-binned, well-driven parts can deliver identical fluence, and only one of them costs more to build.
The second myth is that NIR penetrates to the muscle. Several millimetres into the dermis is the realistic reach for a consumer device, and that is already a useful depth for the tissue it targets. Claims of reaching muscle are both untrue and the kind of statement that attracts regulatory attention.
The third myth treats NIR as a laser. A laser emits a narrow, coherent, single-wavelength beam; an LED emits a broad band across a wide angle. That difference makes the LED safe for unsupervised home use and also makes it less intense, which is why a home device needs longer sessions rather than more power.
The fourth myth is that instant results are achievable. Collagen remodelling is a biological process with a timeline of weeks, and any device promising visible change after one session is either making an unfounded claim or measuring a temporary water and heat effect that fades.
The fifth myth is that certification equals medical approval, a misconception that leads buyers to write listings they cannot defend. Aolemon trains account managers to separate the two, and marks on each spec sheet which numbers are verified output data and which are design targets.